SAN FRANCISCO, February 13-- Nearly 2 billion people worldwide and 100million people in the US are affected by a brain or nervous system disorderincluding addiction, Alzheimer’s, depression, anxiety, schizophrenia,attention disorders, epilepsy, Parkinson’s disease, sensory disorders, andsleep disorders. Diagnosis of these disorders is rapidly changing as newtools are developed for more objective and personalized assessment andtreatment. In addition to the massive unmet markets, long term growth inneurodiagnostics is being driven by 1) technology advances and equipmentupgrades in neuroimaging, 2) new biomarkers and imaging protocols for earlydiagnosis and disease monitoring, and 3) increased use of imaging andinformatics in drug and device development....
